Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 45

1.

Activation of the Mechanistic Target of Rapamycin in SLE: Explosion of Evidence in the Last Five Years.

Oaks Z, Winans T, Huang N, Banki K, Perl A.

Curr Rheumatol Rep. 2016 Dec;18(12):73. doi: 10.1007/s11926-016-0622-8. Review.

2.

Mitochondrial Dysfunction in the Liver and Antiphospholipid Antibody Production Precede Disease Onset and Respond to Rapamycin in Lupus-Prone Mice.

Oaks Z, Winans T, Caza T, Fernandez D, Liu Y, Landas SK, Banki K, Perl A.

Arthritis Rheumatol. 2016 Nov;68(11):2728-2739. doi: 10.1002/art.39791.

3.

Liver injury correlates with biomarkers of autoimmunity and disease activity and represents an organ system involvement in patients with systemic lupus erythematosus.

Liu Y, Yu J, Oaks Z, Marchena-Mendez I, Francis L, Bonilla E, Aleksiejuk P, Patel J, Banki K, Landas SK, Perl A.

Clin Immunol. 2015 Oct;160(2):319-27. doi: 10.1016/j.clim.2015.07.001. Epub 2015 Jul 6.

4.

HRES-1/Rab4 promotes the formation of LC3(+) autophagosomes and the accumulation of mitochondria during autophagy.

Talaber G, Miklossy G, Oaks Z, Liu Y, Tooze SA, Chudakov DM, Banki K, Perl A.

PLoS One. 2014 Jan 3;9(1):e84392. doi: 10.1371/journal.pone.0084392. eCollection 2014.

5.

HRES-1/Rab4-mediated depletion of Drp1 impairs mitochondrial homeostasis and represents a target for treatment in SLE.

Caza TN, Fernandez DR, Talaber G, Oaks Z, Haas M, Madaio MP, Lai ZW, Miklossy G, Singh RR, Chudakov DM, Malorni W, Middleton F, Banki K, Perl A.

Ann Rheum Dis. 2014 Oct;73(10):1888-97. doi: 10.1136/annrheumdis-2013-203794. Epub 2013 Jul 29.

6.

Detection of lupus anticoagulant and successful anticoagulation in familial Sneddon syndrome.

Tily H, Banki K, Hoffman GS, Perl A.

Ann Rheum Dis. 2010 Apr;69(4):775-6. doi: 10.1136/ard.2009.108746. No abstract available.

PMID:
20237126
7.

Cleavage of transaldolase by granzyme B causes the loss of enzymatic activity with retention of antigenicity for multiple sclerosis patients.

Niland B, Miklossy G, Banki K, Biddison WE, Casciola-Rosen L, Rosen A, Martinvalet D, Lieberman J, Perl A.

J Immunol. 2010 Apr 1;184(7):4025-32. doi: 10.4049/jimmunol.0804174. Epub 2010 Mar 1.

8.

Prevention of hepatocarcinogenesis and increased susceptibility to acetaminophen-induced liver failure in transaldolase-deficient mice by N-acetylcysteine.

Hanczko R, Fernandez DR, Doherty E, Qian Y, Vas G, Niland B, Telarico T, Garba A, Banerjee S, Middleton FA, Barrett D, Barcza M, Banki K, Landas SK, Perl A.

J Clin Invest. 2009 Jun;119(6):1546-57. doi: 10.1172/JCI35722. Epub 2009 May 11.

9.

Transaldolase deficiency influences the pentose phosphate pathway, mitochondrial homoeostasis and apoptosis signal processing.

Qian Y, Banerjee S, Grossman CE, Amidon W, Nagy G, Barcza M, Niland B, Karp DR, Middleton FA, Banki K, Perl A.

Biochem J. 2008 Oct 1;415(1):123-34. doi: 10.1042/BJ20080722.

PMID:
18498245
10.

Transaldolase is essential for maintenance of the mitochondrial transmembrane potential and fertility of spermatozoa.

Perl A, Qian Y, Chohan KR, Shirley CR, Amidon W, Banerjee S, Middleton FA, Conkrite KL, Barcza M, Gonchoroff N, Suarez SS, Banki K.

Proc Natl Acad Sci U S A. 2006 Oct 3;103(40):14813-8. Epub 2006 Sep 26.

11.

Regulation of CD4 expression via recycling by HRES-1/RAB4 controls susceptibility to HIV infection.

Nagy G, Ward J, Mosser DD, Koncz A, Gergely P Jr, Stancato C, Qian Y, Fernandez D, Niland B, Grossman CE, Telarico T, Banki K, Perl A.

J Biol Chem. 2006 Nov 10;281(45):34574-91. Epub 2006 Aug 24.

12.

Study of transaldolase deficiency in urine samples by capillary LC-MS/MS.

Vas G, Conkrite K, Amidon W, Qian Y, Bánki K, Perl A.

J Mass Spectrom. 2006 Apr;41(4):463-9.

13.
14.

Leukemoid reaction: a diagnostic clue in metastatic carcinoma mimicking classic Hodgkin lymphoma.

Mukhopadhyay S, Mukhopadhyay S, Banki K, Mahajan S.

Arch Pathol Lab Med. 2004 Dec;128(12):1445-7.

PMID:
15578894
15.

Apoptosis and mitochondrial dysfunction in lymphocytes of patients with systemic lupus erythematosus.

Perl A, Nagy G, Gergely P, Puskas F, Qian Y, Banki K.

Methods Mol Med. 2004;102:87-114.

PMID:
15286382
16.

Mitochondrial hyperpolarization: a checkpoint of T-cell life, death and autoimmunity.

Perl A, Gergely P Jr, Nagy G, Koncz A, Banki K.

Trends Immunol. 2004 Jul;25(7):360-7. Review. No abstract available.

17.

Mitochondrial dysfunction in T cells of patients with systemic lupus erythematosus.

Perl A, Gergely P Jr, Banki K.

Int Rev Immunol. 2004 May-Aug;23(3-4):293-313. Review.

PMID:
15204090
18.

Deletion of Ser-171 causes inactivation, proteasome-mediated degradation and complete deficiency of human transaldolase.

Grossman CE, Niland B, Stancato C, Verhoeven NM, Van Der Knaap MS, Jakobs C, Brown LM, Vajda S, Banki K, Perl A.

Biochem J. 2004 Sep 1;382(Pt 2):725-31.

19.

ZNF143 mediates basal and tissue-specific expression of human transaldolase.

Grossman CE, Qian Y, Banki K, Perl A.

J Biol Chem. 2004 Mar 26;279(13):12190-205. Epub 2003 Dec 31.

20.

Metabolic switches of T-cell activation and apoptosis.

Perl A, Gergely P Jr, Puskas F, Banki K.

Antioxid Redox Signal. 2002 Jun;4(3):427-43. Review.

PMID:
12215210

Supplemental Content

Support Center